Details for New Drug Application (NDA): 018264
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in DANTRIUM is dantrolene sodium. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.
Summary for 018264
Tradename: | DANTRIUM |
Applicant: | Par Sterile Products |
Ingredient: | dantrolene sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018264
Physiological Effect | Decreased Striated Muscle Contraction Decreased Striated Muscle Tone |
Medical Subject Heading (MeSH) Categories for 018264
Suppliers and Packaging for NDA: 018264
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DANTRIUM | dantrolene sodium | INJECTABLE;INJECTION | 018264 | NDA | Par Pharmaceutical, Inc. | 42023-123 | 42023-123-06 | 6 VIAL in 1 CARTON (42023-123-06) / 60 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 018264
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Par Sterile Products | DANTRIUM | dantrolene sodium | INJECTABLE;INJECTION | 018264-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription